| Literature DB >> 15308382 |
Abstract
The appropriate management of patients with type 2 diabetes presents many challenges to health care providers. The first several years of type 2 diabetes are likely to be unrecognized and untreated. The pathophysiology of type 2 diabetes dictates that treatment of insulin resistance should be an early and central focus for every therapeutic program. The pharmacologic tools currently available are capable of allowing most patients with type 2 diabetes to achieve good metabolic control. Implementation of early combination therapy is essential if glycemic targets are to be met.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15308382 DOI： 10.1016/j.mcna.2004.05.002
Source DB: PubMed Journal: Med Clin North Am ISSN： 0025-7125 Impact factor: 5.456